Filing Details

Accession Number:
0001209191-10-045655
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-09-09 21:19:40
Reporting Period:
2010-09-07
Filing Date:
2010-09-09
Accepted Time:
2010-09-09 21:19:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107332 Dendreon Corp DNDN Pharmaceutical Preparations (2834) 223203193
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242879 David Urdal 3005 First Avenue
Seattle WA 98121
Svp, Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-09-07 7,369 $40.66 695,613 No 4 S Direct
Common Stock Disposition 2010-09-07 5,000 $40.41 690,613 No 4 S Direct
Common Stock Disposition 2010-09-08 5,000 $40.37 685,613 No 4 S Direct
Common Stock Disposition 2010-09-08 5,000 $42.00 680,613 No 4 S Direct
Common Stock Disposition 2010-09-09 10,000 $42.55 670,613 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person